How many doses of oral terbinafine 250 mg should be taken over a 12‑week treatment course?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Terbinafine 250mg Daily Dosing: Total Number of Doses Over 12 Weeks

For a standard 12-week treatment course of toenail onychomycosis, you take terbinafine 250 mg once daily for a total of 84 doses (12 weeks × 7 days/week = 84 tablets). 1, 2

Standard Dosing Regimen

One tablet (250 mg) is taken once daily, every single day, for the entire 12-week duration without interruption. 1, 3, 2 This is continuous daily therapy, not pulse therapy—there are no "off" weeks or breaks in treatment. 4

Duration by Indication

  • Toenail onychomycosis: 250 mg once daily for 12 weeks (84 total doses) 1, 3, 2
  • Severe toenail infections: May extend to 16 weeks (112 total doses) 1, 3
  • Fingernail onychomycosis: 250 mg once daily for 6 weeks (42 total doses) 1, 3, 2

Critical Prescribing Details

Continuous daily dosing is superior to intermittent or pulse regimens for terbinafine. 3, 4 A large randomized trial demonstrated that intermittent terbinafine (350 mg daily for 2 weeks on/2 weeks off) was significantly less effective than standard continuous dosing, with complete cure rates approximately 6% lower. 4 Unlike itraconazole, which can be given as pulse therapy, terbinafine must be taken every day without breaks to achieve optimal outcomes. 3, 4

Missed Dose Instructions

If a dose is forgotten, take it as soon as remembered unless less than 4 hours remain before the next scheduled dose—in that case, skip the missed dose. 2 Never double up doses. 2

Why 12 Weeks Is Sufficient

Terbinafine persists in the nail for up to 30 weeks (approximately 6 months) after treatment completion due to its long half-life and lipophilic properties, allowing continued fungicidal activity even after stopping therapy. 1, 3, 5 This pharmacokinetic property is why:

  • You don't need to treat until the nail grows out completely 1, 2
  • Mycological and clinical cure rates continue to improve for months after stopping treatment 5, 6
  • A 12-week course is sufficient for most toenail infections 6

Pre-Treatment Requirements

Baseline liver function tests (ALT and AST) and complete blood count must be obtained before starting terbinafine. 1, 3, 7, 2 This is mandatory for all patients. 2

Enhanced Monitoring Needed For:

  • History of hepatitis or liver disease 1, 7
  • Heavy alcohol consumption 1, 7
  • Concurrent hepatotoxic medications 7
  • Pre-existing abnormal liver enzymes 3, 7

Common Pitfall to Avoid

Do not confuse terbinafine dosing with itraconazole pulse therapy. 3 Itraconazole can be given as 400 mg daily for 1 week per month (pulse dosing), but terbinafine requires continuous daily administration. 3, 4 Attempting to use terbinafine intermittently significantly reduces efficacy. 4

Expected Timeline for Results

The optimal clinical effect appears several months after completing treatment and achieving mycological cure, due to the time required for healthy nail outgrowth. 2 Patients should be followed for at least 48 weeks from treatment initiation to assess response and detect potential relapse. 3

References

Guideline

Terbinafine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Severe Onychomycosis and Symptomatic Tinea Pedis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Terbinafine: a review of its use in onychomycosis in adults.

American journal of clinical dermatology, 2003

Guideline

Guidelines for LFT Monitoring with Oral Terbinafine for Onychomycosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the side effects of onychomycosis treatment, particularly with terbinafine?
What is the recommended dose and treatment duration of terbinafine (antifungal medication) for a patient with nail fungus, considering factors such as location of infection and potential liver or renal impairment?
What is the recommended oral dosing of terbinafine (Lamisil) for adults?
What is the recommended treatment and dosage for oral terbinafine (antifungal medication) in patients with fungal infections such as onychomycosis (fungal infection of the nail)?
What is the recommended treatment regimen for a patient with a fungal infection, specifically onychomycosis, using Terbenifine (Terbinafine)?
What additional pharmacologic and non‑pharmacologic treatments can be used for acute bilateral hip pain of sudden onset 2–3 days ago, with a 10/10 explosion waking the patient from sleep, continuous 30‑minute episodes unrelieved by positioning or acetaminophen, while the patient is already taking tramadol as needed and cyclobenzaprine 5 mg three times weekly?
In an 8-year-old child with poorly controlled asthma presenting to the emergency department with a severe exacerbation and non‑adherence to inhaled therapy, what is the most appropriate immediate management step?
What is the significance and recommended management of a total white blood cell count of 3.4 ×10⁹/L, relative monocytosis of 15.7 %, and absolute neutrophil count of 1.2 ×10⁹/L?
An older adult with Alzheimer disease on donepezil for 6 months has declined from an MMSE of 19 to 12; what medication change is most appropriate?
In an adult without known renal disease who has overdosed on vitamin D, will hypercalciuria (calcium in the urine) occur?
What is the most likely diagnosis and recommended management for a jaundiced adult with total bilirubin 9.7 mg/dL, alkaline phosphatase (ALP) 251 IU/L, aspartate aminotransferase (AST) 34 IU/L, alanine aminotransferase (ALT) 19 IU/L, albumin 2.3 g/dL, total protein 4.7 g/dL, macrocytic anemia (mean corpuscular volume 111 fL), platelets 81 ×10⁹/L, ammonia 71 µmol/L, glucose 182 mg/dL, metabolic alkalosis (CO₂ 34 mmol/L), hypokalemia (potassium 3.4 mmol/L), hypocalcemia (calcium 7.9 mg/dL), and normal creatinine with glomerular filtration rate (GFR) 112 mL/min/1.73 m²?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.